Jack A. Khattar - 28 Feb 2025 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Reporting relationship: President, CEO, Director
Issuer ticker: SUPN
Reported as of: 28 Feb 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Mar 2025, 16:21:31 UTC
Prior SEC filing: 21 Feb 2025
Next SEC filing: 07 Mar 2025
Source filing: View source filing
Reporting owner signature: /s/ Timothy C. Dec, as attorney-in-fact

Key filing fact

Jack A. Khattar filed Form 4 for SUPERNUS PHARMACEUTICALS, INC. (SUPN) on 04 Mar 2025.

Key facts

This page summarizes Jack A. Khattar's Form 4 filing for SUPERNUS PHARMACEUTICALS, INC. (SUPN).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 04 Mar 2025, 16:21.

Change

Previous filing in this sequence was filed on 21 Feb 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SUPN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 953,579
Date: 28 Feb 2025
Ownership: Direct

SUPN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,022,450
Date: 28 Feb 2025
Ownership: By the KBT Trust

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SUPN transaction Derivative

Performance Share Unit

Award

Transaction value: $0
Shares: +35,000
Change %
Price: $0.000000
Shares after: 35,000
Date: 28 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 35,000
Exercise price: $0.000000
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023.